Nonconformist
发表于 2025-3-23 12:49:50
http://reply.papertrans.cn/23/2220/221947/221947_11.png
Ruptured-Disk
发表于 2025-3-23 16:12:56
Cost-Effectiveness of Percutaneous Coronary Interventionsately, much of this coverage is negative and repeats a single troublesome question: Is the United States spending too much for health care and getting too little in return? One area that has received particular scrutiny in recent years, and is likely to remain under close watch in the future, is coronary revascularization.
progestin
发表于 2025-3-23 20:28:04
http://reply.papertrans.cn/23/2220/221947/221947_13.png
不透明
发表于 2025-3-24 01:57:37
https://doi.org/10.1007/978-3-030-13876-9treatment strategy is labeled as A, and the current standard of care strategy is labeled as B, then Table 1 identifies nine potential patterns in which treatment A can affect survival and quality of life in comparison with strategy B.
ERUPT
发表于 2025-3-24 05:09:27
http://reply.papertrans.cn/23/2220/221947/221947_15.png
instructive
发表于 2025-3-24 09:05:09
http://reply.papertrans.cn/23/2220/221947/221947_16.png
EXULT
发表于 2025-3-24 12:29:10
http://reply.papertrans.cn/23/2220/221947/221947_17.png
嘲弄
发表于 2025-3-24 17:03:10
Indirect Health Care Costsreduction of work productivity as a result of the morbidity and mortality associated with a given disease. Indirect costs typically consist of work loss, worker replacement, and reduced productivity from illness and disease. These losses are typically valued from either societal, individual, or employer perspectives .,..
Commonwealth
发表于 2025-3-24 20:19:56
Economics of Therapy for Acute Coronary Syndromesmic analyses of these syndromes and their therapies are typically focused on the initial hospitalization. Conceptually, therefore, it is useful to divide the costs of care for ACS into five major categories (Fig. 1).
calamity
发表于 2025-3-25 02:00:16
Congestive Heart Failureong patients with heart failure. Many do so in a cost-effective manner. In this chapter we define heart failure, review its epidemiology and economic burden, and discuss heart failure management from the perspective of economic issues, with a focus on cost-effectiveness.